Ann Killoran, MD
Neurology · Iowa City, IANPI 1619196565
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $954 of the $1,237 with a category attached, or 77.1%. Every reported general payment came from a single manufacturer, Sage Therapeutics, LLC.
Across 12 payments — averaging $103.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$1K
Across 45 payments — averaging $11,208 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sage Therapeutics, LLC$248K
- Genentech, Inc.$122K
- UCB SA$105K
- Acadia Pharmaceuticals Inc$17K
- Roche TCRC, Inc.$12K
What the payments were for
- Travel & lodging$95477%
- Food & beverage$28323%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 12 | $1,237 |
How this compares
$1,237 in reported general payments places this provider in the 65th percentile of 132 neurology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 100 | $675,904 |
| NuplazidPimavanserin Tartrate | 40 | $216,228 |
| IngrezzaValbenazine Tosylate | 15 | $121,844 |
| Tetrabenazine | 117 | $113,190 |
| NourianzIstradefylline | 31 | $71,751 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 828 | $27,512 |
| NeuproRotigotine | 14 | $12,132 |
| MyrbetriqMirabegron | 35 | $9,526 |
| AmantadineAmantadine Hcl | 218 | $9,484 |
| RivastigmineRivastigmine Tartrate | 117 | $6,560 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 214 | $6,212 |
| Entacapone | 40 | $4,682 |
| Ropinirole Hcl | 211 | $4,326 |
| Rasagiline Mesylate | 17 | $3,289 |
| Primidone | 60 | $2,319 |
Paid to pharmacies, not to this prescriber.
Other neurology in Iowa City
- Douglas NathansonIowa City$47K
- Sami Al KasabIowa City$11K
- Sikawat ThanaviratananichIowa City$4K
- Jun KimuraIowa City$3K
- Tracey ChoIowa City$3K
- Peyman Petram FarIowa City$3K
- Aygun AsgarliIowa City$2K
- Devakumaran KumarIowa City$1K
- Christine GillIowa City$974
- Lee NeilsonIowa City$919
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.